Globus Medical Gains Market Shares in the U.S. Spinal Business – Revenue Growth Surprises with Nearly 17%!
Reading Time: 1 minute
The medical technology company Globus Medical (GMED) is regarded as a specialist in treating musculoskeletal disorders and has become a global leader with the acquisition of NuVasive. Particularly, the U.S. spinal business has recently experienced a sustained acceleration in growth, where CEO Keith Pfeil also points to market share gains. The rapid integration of neuromodulation specialist Nevro presents an additional market opportunity worth $2.5 billion through synergy effects in pain management. With the Excelsius platform, over 115,000...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
